I have completed 3 of the 4 first month injections and have lost 6 pounds
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
10.1016/j.virusres.2012.11.003 139 SchenkP
If you have been battling with your weight for a long period of time or are simply wanting to drop those extra pounds that never seem to go away she can help you lose weight with an functional approach that provides you with the most effective weight loss solutions designed just for you.
future studies will shed light on whether semaglutide can compete (or synergize) with non-GLP-1 drugs like resmetirom (Madrigal, 30% resolution at 52 weeks), efuxifermin (Akero) and Lanifibranor (Inventiva) that are in late stage clinical testing for NASH
doi: 10.1093/procel/pwaf020 112 MizutaniTAnoTYoshiokaYMizutaSTakemotoKOuchiYet al